Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02193269 · ClinicalTrials.gov registry record · Phase 1
The Effects of Minocycline in Humans
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT02193269 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 10 participants.
The verdict
NCT02193269, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
To determine minocycline's effects on cognitive performance and measures of mood in abstinent cocaine users. Minocycline is a tetracycline derivative antibiotic that also inhibits microglia activation and the release of pro-inflammatory cytokines, chemokines, and nitric oxide (NO) production. Previous animal and human studies suggest that minocycline may have utility as a treatment for cocaine addiction.
Interventions
- DRUG Minocycline
- DRUG Sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-07-08 |
| Est. Completion | 2015-11-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02193269
The ClinicalTrials.gov registry entry for NCT02193269 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Minocycline is the first listed.
NCT02193269 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02193269 about?
NCT02193269 is a clinical study titled "The Effects of Minocycline in Humans". To determine minocycline's effects on cognitive performance and measures of mood in abstinent cocaine users. Minocycline is a tetracycline derivative antibiotic that also inhibits microglia activation and the release of pro-inflammatory cytokines, chemokines, and nitric oxide (NO) production. Previo...
What is the current status of trial NCT02193269?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2013-07-08. Estimated completion is 2015-11-05.
What interventions are being tested in trial NCT02193269?
The interventions under investigation include: Minocycline (DRUG), Sugar pill (DRUG).
Who is sponsoring clinical trial NCT02193269?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.